Illicit Cigarettes in European Union at Highest Level Since 2015, KPMG Study Shows
Philip Morris International Inc. (
NYSE: PM) today issues an urgent call for effective policymaking to counter the growing threat of illicit trade in the EU. In 2024, 38.9 billion illicit cigarettes were consumed in the region—the highest level since 2015—accounting for 9.2% of total cigarette consumption, with governments losing as much as €14.9 billion in tax revenues at a time when many countries face intense economic pressures.
Philip Morris International CEO Jacek Olczak Addresses Emerging Global Divide in Regulatory Approaches to Consumer Innovation
Jacek Olczak, Chief Executive Officer of Philip Morris International Inc. (
NYSE: PM), outlined the need for common-sense regulations in the consumer goods sector while addressing global leaders at Semafor’s annual World Economy Summit in Washington, D.C., on April 25, 2025. Olczak emphasized the sector’s potential for innovation-led growth despite the volatile economic environment. He stressed, however, that without appropriate regulation and policy frameworks to enable scientific evaluation and consumer access, promising breakthroughs—such as innovations in wellness, food, and personal care products—could become missed opportunities.
IQOS Collaborates with Italian Design Brand SELETTI: Introducing the 'Curious X: Sensorium Piazza' at Milan Design Week
In support of Philip Morris International’s (
NYSE: PM) mission to make cigarettes obsolete, and to celebrate its ever-growing community of more than 32 million users worldwide – IQOS is proud to announce its collaboration with iconic design brand SELETTI at Milan Design Week.
Philip Morris International Releases Integrated Report Detailing Progress Towards Its Smoke-Free Vision
Philip Morris International Inc. (
NYSE: PM) today published its sixth annual Integrated Report, marking the company’s 10th year of business transformation and sustainability disclosures. The document details PMI’s continued progress in delivering long-term value to shareholders and other stakeholders while advancing its purpose of having its smoke-free alternatives make cigarettes obsolete as soon as possible.
Multinational Survey by Philip Morris International Demonstrates Need for Greater Collaboration to Advance Innovation
The challenges facing our world can overwhelm, but most people strongly believe in innovation’s potential to address the most critical issues in the next 10–20 years, according to the results of a new independent survey commissioned by Philip Morris International Inc. (
NYSE: PM). Conducted by Povaddo in 10 countries in Africa, the Americas, Asia, and Europe, the survey and resultant white paper “Innovation Under Pressure: Navigating Complexity to Drive Change” explore the challenges innovation must overcome to drive societal change, including misinformation, outdated biases, and policymakers’ inability to keep up with rapid technological advances.
FDA Authorizes All ZYN Nicotine Pouch Products Currently Marketed by Swedish Match in the U.S.
The U.S. Food and Drug Administration (FDA) today authorized ZYN nicotine pouches making ZYN the first and only authorized nicotine pouch in the United States. The FDA’s authorization of all ZYN nicotine pouches currently marketed by Swedish Match in the U.S. is an important step to protect the public health by providing better alternatives to cigarettes and other traditional tobacco products for adults 21+.
Philip Morris International Marks a Decade of IQOS—a Milestone in the Journey to a Smoke-Free Future
Philip Morris International Inc. (PMI) (
NYSE: PM) marks the 10th anniversary of the introduction of its leading smoke-free product, IQOS. The launch of this smoke-free innovation was a breakthrough moment toward achieving the company’s commitment to a future without cigarettes.
FDA Reauthorizes Swedish Match’s General snus as a Modified Risk Tobacco Product
The U.S. Food and Drug Administration (FDA) authorized a renewal of a risk modification order submitted by Swedish Match USA, Inc. (Swedish Match), an affiliate of Philip Morris International, Inc. (PMI) (
NYSE: PM), for eight General snus products. As part of the authorization, the agency granted use of the modified risk claim to reach more adults 21+ who smoke or use traditional tobacco products. The agency concluded that renewing the General snus risk modification order will significantly reduce harm and the risk of tobacco-related disease to individual tobacco users and benefit the health of the population as a whole.
